We provide the Obruza Screening System, an automated system for the testing and imaging of new pharmaceutical compounds on standard cell cultures. Companies involved in the development of new pharmaceutical compounds must run a series of test to see how their new compounds interact with human cells in the body. Our focus is on automating the process of high-throughput screening and imaging for cell based assays in a singe integrated device.